Moderna Publishes Positive Phase 3 Clinical Data for mRNA-1010 Seasonal Influenza Vaccine in New England Journal of Medicine
CAMBRIDGE, Mass., May 6, 2026 Moderna announced the publication of pivotal Phase 3 clinical safety and efficacy data for...
respiratory vaccines
Advertisement
DIFF-flu Nasal Vaccine Gains China Clinical Approval
BEIJING, China, Feb. 10, 2026 — DIFF Biotech announced that its proprietary intranasal influenza vaccine candidate, DIFF-flu, has received...
Sanofi Strengthens Vaccine Pipeline with Acquisition of Vicebio
Paris, France — August 21, 2025 – Sanofi has announced the acquisition of Vicebio, a biotechnology company specializing in...
Advertisement
